Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
14 October 2022 | Story Dr Cinde Greyling | Photo Iflair Photography
UFS Business school
The UFS Business School.

The University of the Free State Business School (UFSBS) was established in the late 1990s and is fully accredited by the Council on Higher Education (CHE) and the Central and East European Management  Development Association (CEEMAN). Since its inception, the school has operated as a boutique business school focusing on personal attention to adult learners.

Late 2021, the UFSBS appointed a new Director, Dr Udesh Pillay. In conjunction with the change in leadership, the UFSBS is embarking on a new strategic journey, while maintaining the focus on its core business – in other words, its official academic offerings. The strategic journey of the UFSBS has been underway for the past year, and significant time has been allocated to the recurriculation of programme offerings; decolonisation of the academic agenda; and orientating the UFSBS so that it makes a larger practical contribution to the SME sector locally and nationally, especially in relation to business continuity and resilience in the wake of unforeseen externalities.  These developments will ensure that the UFSBS remains a premier academic institution and contributes to the success of South Africa and its people. It also ensures that the twin principles of academic excellence and social justice become mutually reinforcing.

The UFSBS’s strategic direction for the next five years aligns neatly with the Vision 130. By 2034 – when the university commemorates its 130th anniversary – the UFS wants to be recognised and acknowledged by peers and society as a top-tier university in South Africa. Similarly, the UFSBS has aspirations to become a top-ten business school in SA over the next five years.

Given the history of South Africa, it is of utmost importance to empower people to add value, particularly in the field of business and management leadership. The UFSBS will contribute to building an ecosystem of entrepreneurialism, with the more traditional academic programmes based upon the conventional practices of teaching and learning, research, and mentorship to be supplemented by ‘opportunity-driven initiatives’, such as executive education, consulting support, coaching, incubation services, and the commercialisation of intellectual property.

Globally, the Fourth Industrial Revolution (4IR) has catalysed processes of digital transformation in business, to which the UFSBS will align to ensure that students are equipped with the relevant knowledge and skills in a fast-changing, technology-enabled world. With the support of the Centre for Business Dynamics (CBD) housed in the UFSBS; the establishment of the Small Business Academy (SBA) in early 2024 in the UFSBS; the soon-to-be-established High-Growth Business Incubator (in collaboration with the NAS faculty); and with the process of strengthening relationships with the Paradys Experimental Farm gaining traction, a differentiated medium has been created to nurture responsible,  ethical, and socially conscious business leaders. The foundation then – to create the next generation of business leaders and entrepreneurs to become agents of change and value co-creators for business and society – will thus have begun.

The UFSBS will align to ensure that students are equipped with relevant knowledge and skills in a fast-changing, technology-enabled world. – Dr Udesh Pillay.
The slogan, ‘BE WORTH MORE’, embodies what the UFSBS strives for, and is consistent with new developments in global discourses, which are rethinking and transforming many of the traditional dogmas that have informed the mandates of business schools. 

As a critical bridge between academia and business, the UFSBS is uniquely poised to reimagine a better and intelligent future that is data-informed, collaborative, innovative, and inclusive.

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept